A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
- Conditions
- Arthritis, Juvenile Rheumatoid
- First Posted Date
- 2006-01-20
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 226
- Registration Number
- NCT00279747
- Locations
- 🇦🇹
Univ.-Klinik für Kinder- und Jugendheilkunde Wien, Wien, Austria
🇦🇹Gottfried Preyersches Kinderspital d. Stadt Wien, Wien, Austria
🇧🇪UZ Gent, Gent, Belgium
Spiriva® Assessment of FEV1 (SAFE)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 914
- Registration Number
- NCT00277264
- Locations
- 🇨🇦
Penticton Regional Hospital, Penticton, British Columbia, Canada
🇨🇦220 Royal Avenue, New Westminster, British Columbia, Canada
🇨🇦825 Coxwell Avenue, Toronto, Ontario, Canada
Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 346
- Registration Number
- NCT00275457
- Locations
- 🇦🇹
Univ.-Klinik für Neurologie, Innsbruck, Austria
🇸🇪Boehringer Ingelheim Investigational Site, Örebro, Sweden
🇦🇹Confraternität Privatklinik, Wien, Austria
3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
- Conditions
- HIV Infections
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 216
- Registration Number
- NCT00275444
- Locations
- 🇺🇸
Mercer University School of Medicine, Macon, Georgia, United States
🇺🇸John's Hopkins University, Baltimore, Maryland, United States
🇺🇸Rush-Presbytarian-St Luke's Medical Center, Chicago, Illinois, United States
A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 36
- Registration Number
- NCT00274534
- Locations
- 🇺🇸
Hunter Holmes McGuire Medical Center, Richmond, Virginia, United States
🇺🇸Hines Veterans Administration Hospital, Hines, Illinois, United States
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
- Conditions
- Hypertension
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 812
- Registration Number
- NCT00274599
- Locations
- 🇺🇸
Spartanburg Medical Research, Spartanburg, South Carolina, United States
🇺🇸Harold B. Betton, M.D., Little Rock, Arkansas, United States
🇺🇸GFI Pharmaceuticals, Evansville, Indiana, United States
Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1639
- Registration Number
- NCT00274573
- Locations
- 🇩🇪
Boehringer Ingelheim Investigational Site, Zwickau, Germany
🇩🇪MEDARS GmbH, Berlin, Germany
🇩🇪Johannes-Gutenberg-Universität Mainz, Mainz, Germany
Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 261
- Registration Number
- NCT00274508
- Locations
- 🇺🇸
St. Thomas Health Services, Nashville, Tennessee, United States
🇺🇸Presbyterian Hospital of Dallas, Dallas, Texas, United States
🇨🇦Department of Respiratory Medicine, Toronto, Ontario, Canada
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)
- Conditions
- Hypertension
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-12-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 805
- Registration Number
- NCT00274638
- Locations
- 🇺🇸
Herron Medical Center, Ltd., Chicago, Illinois, United States
🇺🇸Midwest Institute for Clinical Research Inc., Indianapolis, Indiana, United States
🇺🇸nTouch Research, Houston, Texas, United States
Tiotropium (Spiriva) Rehabilitation Study
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 108
- Registration Number
- NCT00274521
- Locations
- 🇺🇸
Harbor-UCLA Research and Education Institute, Torrance, California, United States
🇺🇸St. Francis Hospital and Medical Center, Hartford, Connecticut, United States
🇺🇸Temple University Hospital, Philadelphia, Pennsylvania, United States